CERA is led by a multi-disciplinary team with advanced expertise in genomics, bioethics, legal analysis, social science research, and related fields. The CERA leadership identifies priority areas in ELSI, ensures the integrity of our collection of ELSI resources and analysis, and guides the community building and engagement activities of the Center.
Dana Waring Bateman, M.L.A.
Dana Waring Bateman, M.L.A. is the Education Director and Co-founder of the Personal Genetics Education Project (pgEd). Her expertise includes the social, familial and legal landscape in personal genetics, and she has a special interest in health disparities, the genetics of complex traits, and the use of genetics in the criminal justice system.
Carolyn P. Neuhaus, Ph.D.
Carolyn P. Neuhaus, Ph.D. is a Bioethicist at The Hastings Center. She explores philosophical and ethical questions that arise throughout biomedical research, especially in the development of genetic technologies, digital medicine, and artificial intelligence. Her postdoctoral research focused on the use of genome editing tools in nonhuman organisms.
Marnie Gelbart, Ph.D.
Marnie Gelbart, Ph.D. leads initiatives for increasing awareness and conversation about the benefits and the ethical, legal, and social implications of genetic advances, in her role as Director of Programs at the Personal Genetics Education Project (pgEd) at Harvard University.
Maya Sabatello, LL.B., Ph.D.
Maya Sabatello, LL.B., Ph.D. is Associate Professor of Clinical Bioethics at Columbia University. She specializes in bioethics, disability studies, and international/comparative human rights. Her research focuses on law, society, medicine, and disability; assisted reproductive technologies; and the ethical, legal, and social implications of genetics, especially in pediatrics and underserved populations.
Mark Musen, M.D., Ph.D.
Mark Musen, M.D., Ph.D. is Professor of Biomedical Informatics at Stanford University, where he is Director of the Stanford Center for Biomedical Informatics Research. Dr. Musen conducts research related to intelligent systems, reusable ontologies, metadata for publication of scientific data sets, and biomedical decision support.
David Magnus, Ph.D.
David Magnus, Ph.D. is the Director of the Stanford Center for Biomedical Ethics, and Thomas A. Raffin Professor of Medicine and Biomedical Ethics, as well as Professor of Pediatrics. He is the Vice-Chair of the NIH Precision Medicine Initiative “All of Us Research Program” IRB and is Editor-in-Chief of the American Journal of Bioethics and of bioethics.net.